Downloads: 125 | Views: 306
Comparative Studies | Biological Engineering | India | Volume 4 Issue 12, December 2015 | Popularity: 6.2 / 10
Multi Drug Therapy- Combination of Structural Inhibitors to Eradicate Leprosy
Vandana Kashyap, Astha Pandey, Swati Tripathi
Abstract: Being persistant infection, caused by Mycobacterium leprae, Leprosy is affecting about 50, 000 annually. It affects Schwann cells (the glial cells of peripheral nervous system) and macrophages. Its long incubation period (5-7 years) classify leprosy as paucibacillary (PB) and multibacillary (MB) depending on the bacillary load. Recent advances have been made in developing molecular diagnostics, in identifying and designing highly effective treatment. MULTI DRUG THERAPY (MDT) has revamped leprosy with the combination of rifampicin, clofazimine and dapsone (MB patients) and rifampicin and dapsone (PB patients). Various new agents like fluroquinolones (moxifloxacin), rifapentine, macrolides and monocycline in varying combination have also proved their potency. Drugs like thalidomide analogues, pentoxifyline, selectively inhibit cytokine and control type-2 reactions (erythema nodosum leprosum reaction) which have association with deposition of tissue and circulation of immune complex. Present study discusses about the high potential effect of MDT over other treatments through complex structural comparison and their interactions.
Keywords: Mycobacterium leprae, Schwann cells, Paucibacillary, Multibacillary, erythema nodosum leprosum
Edition: Volume 4 Issue 12, December 2015
Pages: 397 - 398
DOI: https://www.doi.org/10.21275/NOV151919
Make Sure to Disable the Pop-Up Blocker of Web Browser
